Literature DB >> 8259387

Neural crest tumors: I-123 MIBG imaging in children.

H J Paltiel1, M J Gelfand, A H Elgazzar, L C Washburn, R E Harris, P R Masters, G J Golsch.   

Abstract

PURPOSE: To determine 24- and 48-hour distribution of iodine-123 metaiodobenzylguanidine (MIBG) and to establish an optimized pediatric imaging protocol.
MATERIALS AND METHODS: Seventy-seven I-123 MIBG scans obtained in 33 children undergoing evaluation for neural crest tumor were reviewed.
RESULTS: Activity in the salivary glands, myocardium, liver, gut, and bladder was demonstrated on almost all scans. Activity was noted in the neck muscles, thyroid gland, and uninvolved adrenal gland in fewer studies. In 20 studies, abnormal uptake was present in the chest or abdomen at 24 and 48 hours, and lesion identification was improved at 48 hours in 12 studies. Detection of skeletal lesions on 14 scans was similar at 24 and 48 hours. Foci of tumor were first detected at I-123 MIBG imaging in nine studies, and in only two patients was tumor involvement initially missed on I-123 MIBG studies.
CONCLUSION: Distribution of I-123 MIBG on images in children differs from that in earlier descriptions in adults. Images of the torso at 48 hours after injection are a useful adjunct in detection of lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8259387     DOI: 10.1148/radiology.190.1.8259387

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

2.  High uptake of 123I-metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT.

Authors:  T Sasajima; H Kinouchi; N Tomura; J Watarai; K Mizoi
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

Review 3.  Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.

Authors:  Michael J Gelfand
Journal:  Pediatr Radiol       Date:  2008-12-16

4.  123I-MIBG uptake in the neck and shoulders of a neuroblastoma patient: damage to sympathetic innervation blocks uptake in brown adipose tissue.

Authors:  Michael J Gelfand
Journal:  Pediatr Radiol       Date:  2004-03-03

Review 5.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

6.  Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.

Authors:  N L Hadj-Djilani; N E Lebtahi; A B Delaloye; R Laurini; D Beck
Journal:  Eur J Nucl Med       Date:  1995-04

Review 7.  Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.

Authors:  Jia Xia; Hang Zhang; Qun Hu; Shuang-You Liu; Liu-Qing Zhang; Ai Zhang; Xiao-Ling Zhang; Ya-Qin Wang; Ai-Guo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

8.  Development of Fe3O4 core-TiO2 shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization.

Authors:  William Liu; Salida Mirzoeva; Ye Yuan; Junjing Deng; Si Chen; Barry Lai; Stefan Vogt; Karna Shah; Rahul Shroff; Reiner Bleher; Qiaoling Jin; Nghia Vo; Remon Bazak; Carissa Ritner; Stanley Gutionov; Sumita Raha; Julia Sedlmair; Carol Hirschmugl; Chris Jacobsen; Tatjana Paunesku; John Kalapurkal; Gayle E Woloschak
Journal:  Cancer Nanotechnol       Date:  2021-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.